The over USD 190 billion Indian healthcare and life sciences market is estimated to grow at a compounded annual growth rate (CAGR) of 14 per cent over the next five years and it represents an attractive investment opportunity
Following a continuous downward trend, India’s active caseload has declined to 21,530 today, constituting 0.05 per cent of the country's total positive cases.
The law firm has assisted Venkateshwar Hospital in facilitating multiple engagements in Uzbekistan through its involvement with the India Uzbekistan Investment Corridor
"The UKHSA engagement is a fantastic addition to the UK business, both from a growth and complexity perspective,” said Partha DeSarkar, Executive Director and Group CEO, HGS.